跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TELMISARTAN AUROVITAS 40 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TELMISARTAN AUROVITAS 40 MG COMPRIMIDOS EFG
Approved
STANDARD
TELMISARTAN AUROVITAS 40 MG COMPRIMIDOS EFG
Aurovitas Spain, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 31, 2022
Approval ID
f1a829dca67d2c26
Company
Aurovitas Spain, S.A.U.
Type
Standard
Approval Details
Approval Id
f1a829dca67d2c26
Drug Cima Aemps Name
TELMISARTAN AUROVITAS 40 MG COMPRIMIDOS EFG
Register Number
86721
Holder Company Name
Aurovitas Spain, S.A.U.
Marketing Company Name
Aurovitas Spain, S.A.U.
Authorization Date
2022-03-31
Dosage Form
COMPRIMIDO
Dose
40 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Aurovitas Spain, S.A.U.
Active Ingredients
TELMISARTAN
40 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 31, 2022
Approval ID
f1a829dca67d2c26
Type
Standard
Back to CIMA-AEMPS Approvals
